SNX3P1X

Across TCGA pan-cancer cohorts, SNX3P1X RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated SNX3P1X data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher SNX3P1X RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNX3P1X expression acts as an unfavorable survival marker, although some lineages such as ESCA and GBM show a favorable association.

LIHC, COAD, and THYM are the cancer types where SNX3P1X RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.059	0.777	<.001	108	view →
COAD	OS	Tertile	All	0.125	0.799	<.001	81	view →
THYM	DFS	Tertile	All	0.115	0.827	<.001	54	view →
KIRP	OS	Tertile	II,III,IV	0.161	0.771	.002	45	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	36	view →
LAML	DFS	Tertile	All	0.026	0.572	<.001	36	view →
ESCA	OS	Tertile	III,IV	0.791	0.367	.011	36	view →
THCA	DFS	Tertile	III,IV	0.145	0.825	<.001	27	view →
BLCA	DFS	Tertile	All	0.194	0.521	.044	18	view →
STAD	OS	Tertile	III,IV	0.163	0.517	.026	18	view →
BRCA	DFS	Tertile	III,IV	0.583	0.880	.012	12	view →
GBM	DFS	Tertile	All	0.761	0.188	.015	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

SNX3P1X–LIHC (OS)

Open the LIHC breakdown →